Secondary |
Drug Use For Unknown Indication |
45.8% |
Depression |
10.2% |
Suicide Attempt |
10.2% |
Product Used For Unknown Indication |
5.1% |
Anxiety |
3.4% |
Anxiety Disorder |
3.4% |
Drug Dependence |
3.4% |
Hypothyroidism |
3.4% |
Polyneuropathy |
3.4% |
Status Epilepticus |
3.4% |
Bipolar Disorder |
1.7% |
Extrapyramidal Disorder |
1.7% |
Hypertension |
1.7% |
Premature Labour |
1.7% |
Restless Legs Syndrome |
1.7% |
|
Toxic Epidermal Necrolysis |
19.2% |
Suicide Attempt |
11.5% |
Abortion Missed |
7.7% |
Restlessness |
7.7% |
Sepsis |
7.7% |
Tardive Dyskinesia |
7.7% |
Vascular Encephalopathy |
7.7% |
Drug Exposure During Pregnancy |
3.8% |
Femoral Neck Fracture |
3.8% |
Femur Fracture |
3.8% |
Maternal Exposure During Pregnancy |
3.8% |
Pulmonary Oedema |
3.8% |
Somnolence |
3.8% |
Status Epilepticus |
3.8% |
Ventricular Hypokinesia |
3.8% |
|
Concomitant |
Drug Use For Unknown Indication |
13.7% |
Alopecia |
11.2% |
Depression |
10.9% |
Product Used For Unknown Indication |
10.9% |
Hypertension |
6.2% |
Glaucoma |
5.9% |
Chronic Lymphocytic Leukaemia |
5.7% |
Rheumatoid Arthritis |
5.7% |
Prophylaxis |
4.8% |
Benign Prostatic Hyperplasia |
3.9% |
Pain |
3.6% |
Crohn's Disease |
2.7% |
Breast Cancer |
2.5% |
Osteoporosis |
2.3% |
Hepatitis C |
2.1% |
Hyperlipidaemia |
2.1% |
Myocardial Ischaemia |
1.8% |
Colitis Ulcerative |
1.4% |
Diabetes Mellitus |
1.4% |
Premedication |
1.4% |
|
Pneumonia |
21.4% |
Renal Mass |
8.6% |
Cerebral Haemorrhage |
7.1% |
Myalgia |
5.7% |
Speech Disorder |
5.7% |
Aphasia |
4.3% |
Completed Suicide |
4.3% |
Mitral Valve Incompetence |
4.3% |
Pancytopenia |
4.3% |
Panic Attack |
4.3% |
White Blood Cell Count Decreased |
4.3% |
Acute Generalised Exanthematous Pustulosis |
2.9% |
Bradycardia |
2.9% |
Crohn's Disease |
2.9% |
Depression |
2.9% |
Infusion Related Reaction |
2.9% |
Lower Limb Fracture |
2.9% |
Menorrhagia |
2.9% |
Papillary Tumour Of Renal Pelvis |
2.9% |
Pelvic Fracture |
2.9% |
|
Interacting |
Drug Use For Unknown Indication |
50.0% |
Depression |
28.6% |
Anxiety |
7.1% |
Atrial Fibrillation |
7.1% |
Atrial Flutter |
7.1% |
|
Vascular Encephalopathy |
50.0% |
Drug Interaction |
25.0% |
Mixed Liver Injury |
25.0% |
|